Pharmacokinetics of bezafibrate after single and multiple doses in the presence of renal failure
✍ Scribed by Abshagen, U. ;K�sters, W. ;Kaufmann, B. ;Lang, P. D.
- Publisher
- Springer-Verlag
- Year
- 1980
- Tongue
- English
- Weight
- 773 KB
- Volume
- 58
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Thiopental was administered to neurosurgical patients for cerebral protection and its pharmacokinetic parameters were determined after a single bolus of 540, 1000 or 1500 mg (3 subjects) or after multiple doses of 250 mg (5 subjects) and 500 mg (2 subjects) every two hours for up to 7 days. The data
The pharmacokinetics of a new serotonin 5-HT 2 antagonist, deramciclane, was studied. Single oral doses of 1, 3, 6 and 10 mg kg -1 and intravenous doses of 1, 3 and 6 mg kg -1 were administered in beagle dogs. Moreover, the steady state pharmacokinetics of 1, 3 and 6 mg kg -1 doses were studied. Der